PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Pantethine→

Pantethine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
16816-67-4
Molecular formula
C22H42N4O8S2
Molecular weight
554.7 g/mol
Drug class
Pantothenic-acid-derived lipid-modulating nutrientpantetheine dimer
Mechanism of action
A dimer of pantetheine and a precursor in coenzyme A metabolism. It has been studied for effects on fatty-acid synthesis and HMG-CoA reductase activity and may modestly influence circulating total cholesterol, LDL cholesterol and apolipoprotein B.
Indications / reported uses
  • Marketed in some countries as a nutritional or adjunctive lipid-modulating product. Evidence supports only modest lipid changes in selected studies; it is not a replacement for guideline-directed lipid-lowering medication.

Sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC5575230/ · https://pubchem.ncbi.nlm.nih.gov/#query=pantethine · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Pantethine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Pantethine Permitted Daily Exposure (PDE) report (the Pantethine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Pantethine Occupational Exposure Limit (OEL) report (the Pantethine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.